Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON21263Phase 1Not yet recruiting
Phase 1, single-blind trial of oxycodone and ethanol (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Shift in Vi-CO2 response curve. Planned start Sep 2013; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON21263.